 |
|
Flesh-eating bacteria escape body's safety net
February 21, 2006Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that so-called flesh-eating "Strep" bacteria use a specific enzyme to break free of the body's immune system, a finding which could potentially lead to new treatments for serious infections in human patients.
The research, reported in the February 21, 2006 issue of the journal Current Biology, focuses on the major human pathogen group A Streptococcus. Among the most important of all bacterial pathogens, strep is responsible for a wide range of diseases - from simple throat and skin infections to life-threatening conditions such as necrotizing fasciitis ("flesh-eating disease") and toxic shock syndrome.
"These findings suggest a novel approach to treating serious Strep infections, such as flesh-eating disease, by assisting our body's own defense system," said senior author Victor Nizet, M.D., UCSD associate professor of pediatrics and an infectious diseases physician at Children's Hospital, San Diego.
The UCSD investigators examined the interaction of Strep bacteria with neutrophils, specialized white blood cells that play a front line role in human's immune defense against pathogenic microbes. Recent research by European investigators had shown that neutrophils are particularly effective defenders because they release "nets" composed of DNA and toxic compounds to entrap and kill invading bacteria. In the current study, the UCSD scientists proved that disease-causing Strep release an enzyme that degrades these DNA nets, thereby allowing the organism to escape the neutrophil net and spread in body tissues.
The UCSD team used a molecular genetic approach for their studies, knocking out the gene encoding the DNA-degrading enzyme from a pathogenic Strep strain that was originally isolated from a patient suffering from necrotizing fasciitis.
"Deprived of this single enzyme, the mutant Strep strain was easily killed by human neutrophils", said lead author John Buchanan, Ph.D., research scientist in the UCSD department of pediatrics. "In addition, the mutant Strep bacteria no longer produced a spreading infection when injected into the skin of experimental mice."
The critical role of the DNA-degrading Strep enzyme was confirmed by cloning the corresponding gene into a normally non-pathogenic bacterial strain. Addition of the single gene allowed these bacteria to degrade DNA, escape neutrophil killing, and produce a spreading ulcer in the mouse infection model. Special fluorescent microscopy techniques were used to observe how the Strep enzyme dissolved the DNA nets and allowed bacteria to float away from the neutrophils.
"The experiments explain how this DNA-degrading enzyme contributes to the severe infections produced by certain strains of Strep bacteria, while simultaneously confirming just how important neutrophil DNA nets are to our normal immune defense," said Buchanan.
Recognizing the critical role played by the DNA-degrading enzyme in progression of Strep disease, the UCSD researchers examined whether it could represent a target for therapy. Mice experimentally infected with Strep were treated by injecting a chemical inhibitor of the DNA-degrading enzyme at the site of infection. A dramatic reduction in bacterial counts and tissue injury was observed following the inhibitor treatment, when compared to controls receiving a placebo.
Nizet explained that the researchers' findings could lead to novel treatments for Strep-related diseases. "Instead of attempting to kill the bacteria directly with standard antibiotics, a treatment strategy to inhibit the Strep DNA-degrading enzyme could disarm the pathogen, making it susceptible to clearance by our normal immune defenses," he said.
University of California-San Diego
The UCSD investigators examined the interaction of Strep bacteria with neutrophils, specialized white blood cells that play a front line role in human's immune defense against pathogenic microbes. Recent research by European investigators had shown that neutrophils are particularly effective defenders because they release "nets" composed of DNA and toxic compounds to entrap and kill invading bacteria. In the current study, the UCSD scientists proved that disease-causing Strep release an enzyme that degrades these DNA nets, thereby allowing the organism to escape the neutrophil net and spread in body tissues.
The UCSD team used a molecular genetic approach for their studies, knocking out the gene encoding the DNA-degrading enzyme from a pathogenic Strep strain that was originally isolated from a patient suffering from necrotizing fasciitis.
"Deprived of this single enzyme, the mutant Strep strain was easily killed by human neutrophils", said lead author John Buchanan, Ph.D., research scientist in the UCSD department of pediatrics. "In addition, the mutant Strep bacteria no longer produced a spreading infection when injected into the skin of experimental mice."
The critical role of the DNA-degrading Strep enzyme was confirmed by cloning the corresponding gene into a normally non-pathogenic bacterial strain. Addition of the single gene allowed these bacteria to degrade DNA, escape neutrophil killing, and produce a spreading ulcer in the mouse infection model. Special fluorescent microscopy techniques were used to observe how the Strep enzyme dissolved the DNA nets and allowed bacteria to float away from the neutrophils.
"The experiments explain how this DNA-degrading enzyme contributes to the severe infections produced by certain strains of Strep bacteria, while simultaneously confirming just how important neutrophil DNA nets are to our normal immune defense," said Buchanan.
Recognizing the critical role played by the DNA-degrading enzyme in progression of Strep disease, the UCSD researchers examined whether it could represent a target for therapy. Mice experimentally infected with Strep were treated by injecting a chemical inhibitor of the DNA-degrading enzyme at the site of infection. A dramatic reduction in bacterial counts and tissue injury was observed following the inhibitor treatment, when compared to controls receiving a placebo.
Nizet explained that the researchers' findings could lead to novel treatments for Strep-related diseases. "Instead of attempting to kill the bacteria directly with standard antibiotics, a treatment strategy to inhibit the Strep DNA-degrading enzyme could disarm the pathogen, making it susceptible to clearance by our normal immune defenses," he said.
University of California-San Diego
Blood tests can help detect presence of necrotizing soft tissue infections
With less than half of patients with necrotizing soft tissue infections displaying the physical signs of these very serious infections, researchers have found two simple blood tests can help physicians diagnose what is commonly known as "flesh-eating bacteria," according to a study in the December issue of The American Journal of Surgery.
Social habits of cells may hold key to fighting diseases
Scientists in Manchester are working to change the social habits of living cells - an innovation that could bring about cleaner and greener fuel and help fight diseases such as cancer and diabetes.
The results are in: Bacterial parasite strives for balance in host infection
When horror-movie writers run out of ideas, they can always turn to parasites. Imagine the possibilities with flesh-eating bacteria, suicide-inducing hairworms, scalp burrowing botflies—and castrating parasites.
More Flesh-eating Bacteria Current Events and Flesh-eating Bacteria News Articles
 |
Surviving the Flesh-eating Bacteria: Understanding, Preventing, Treating, and Living with Necrotizing Fascitis by Jacqueline A. Roemmele (Author), Donna Batdorff (Author) Recent stories in the national media have focused on the effects of "flesh-eating bacteria," known to the medical community as necrotizing fasciitis (NF), but most people know nothing about the realities of this disease. In fact, NF is an infection commonly caused by Strep A bacteria that rapidly destroys tissue. The disease is often fatal, and until now, there has been no useful information available to the general public. This is the first comprehensive book geared to survivors of the disease, their families, and anyone wishing to learn more about NF. |
 |
A Night At Global Dynamics Starring: Colin Ferguson, Salli Richardson, Joe Morton, Jordan Hinson, Ed Quinn Directed By: Michael Lange Also With: Jamie Paglia (Producer), Wendy Wallace (Producer), Jaime Paglia (Writer) |
 |
Flesh Eating Bacteria & Failure to Appear (Live 2007) Goatbag (Primary Contributor) |
|
Miracle Victory over the Flesh-Eating Bacteria by David L. Cowles (Author), Delys Cowles (Author) David Cowles believed he had contracted flu while on a family holiday, the illness, however, proved to be a rare flesh-eating disease. In this book, David and his wife give accounts of their struggle with the disease, the faith they needed to survive it, and David's miracle recovery. | |
|
The 13 Year Trial: How a Group of Plastic Surgeons Used Corrupt Government & Flesh-Eating Bacteria to Disfigure the Image of a Fellow Doctor (Special Edition) by Doris Ramirez (Author) How a group of plastic surgeons used corrupt government & flesh-eating baceria to disfigure the image of a fellow doctor. | |
![A Night At Global Dynamics [HD]](http://ecx.images-amazon.com/images/I/61lcRMT6gzL._SL160_.jpg) |
A Night At Global Dynamics [HD] Starring: Colin Ferguson, Salli Richardson, Joe Morton, Jordan Hinson, Ed Quinn Directed By: Michael Lange Also With: Jamie Paglia (Producer), Wendy Wallace (Producer), Jaime Paglia (Writer) |
 |
Help! What's Eating My Flesh?: Runaway Staph and Strep Infections! (24/7: Science Behind the Scenes) by Thomasine E. Lewis Tilden (Author) Medical Files examines the science and technology behind some of the most fascinating medical cases and mysteries, from flesh-eating diseases to deadly mosquito bites, and more. |
| © 2009 BrightSurf.com |